Ondine Biomedical Inc. (AIM: OBI)
London flag London · Delayed Price · Currency is GBP · Price in GBX
8.06
-0.44 (-5.15%)
Nov 19, 2024, 9:17 AM GMT+1

Ondine Biomedical Ratios and Metrics

Millions GBP. Fiscal year is Jan - Dec.
Fiscal Year
CurrentFY 2023 FY 2022 FY 2021 FY 2020 FY 2010 2009 - 2005
Period Ending
Nov '24 Dec '23 Dec '22 Dec '21 Dec '20 Dec '10 2009 - 2005
Market Capitalization
232040108--
Upgrade
Market Cap Growth
-11.83%-50.26%-63.06%---
Upgrade
Enterprise Value
221827128--
Upgrade
Last Close Price
0.080.090.200.56--
Upgrade
PS Ratio
18.9727.74101.9672.03--
Upgrade
PB Ratio
1956.3416.015.596.24--
Upgrade
P/TBV Ratio
1956.3416.015.596.24--
Upgrade
EV/Sales Ratio
23.3224.9069.7485.23--
Upgrade
Debt / Equity Ratio
18.470.260.120.02-1.041.79
Upgrade
Asset Turnover
0.290.110.030.14-0.59
Upgrade
Inventory Turnover
0.550.420.301.80-1.16
Upgrade
Quick Ratio
0.360.953.417.810.030.54
Upgrade
Current Ratio
0.801.363.878.540.050.78
Upgrade
Return on Equity (ROE)
-685.59%-209.95%-93.81%---418.34%
Upgrade
Return on Assets (ROA)
-159.71%-82.98%-46.25%-59.55%--101.40%
Upgrade
Return on Capital (ROIC)
-330.37%-118.27%-54.06%-69.33%--254.03%
Upgrade
Earnings Yield
-38.40%-43.18%-29.78%-27.07%--
Upgrade
FCF Yield
-33.83%-41.44%-25.60%-6.82%--
Upgrade
Buyback Yield / Dilution
-13.24%-1.30%-144.34%-12.69%-761.95%-48.67%
Upgrade
Total Shareholder Return
-13.24%-1.30%-144.34%-12.69%-761.95%-48.67%
Upgrade
Source: S&P Capital IQ. Standard template. Financial Sources.